TLC Biopharmaceutical

Titan Pharmaceuticals, Inc. is a development-stage biotechnology company based in South San Francisco, CA. They specialize in developing proprietary therapeutics using their clinically proven ProNeura long-term, continuous drug delivery technology, which has the potential to revolutionize the treatment of chronic conditions by maintaining consistent, around-the-clock blood levels of medication.

With a focus on innovation in medicine, Titan Pharmaceuticals is advancing the treatment of select chronic diseases through their product pipeline, which includes the Kappa Opioid Receptor Agonist Nalmefene Implant and the TP-2021 Implant for the treatment of moderate-to-severe chronic pruritus. Their mission is to improve medical outcomes and benefit patients by delivering low-dose, non-fluctuating medication levels for extended periods following a single subdermal insertion procedure.

Generated from the website